Bayer HealthCare Pharmaceuticals Inc. drugs

26 results

  • Adempas

    (riociguat)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Adempas is indicated for adults with chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatment or if inoperable, as well as for pulmonary arterial hypertension (PAH). It improves exercise capacity, WHO functional class, and delays clinical worsening. The drug is effective as monotherapy or in combination with other treatments.

  • Aliqopa

    (copanlisib)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: ALIQOPA is indicated for adult patients with relapsed follicular lymphoma (FL) who have undergone at least two prior systemic therapies. Its accelerated approval is based on overall response rates, with continued approval dependent on further confirmation of clinical benefit.

  • Betaseron

    (interferon beta-1b)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

  • Cipro (ciprofloxacin hydrochloride)

    (ciprofloxacin hydrochloride)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: CIPRO is indicated for treating various infections in adults, including skin and structure infections, bone and joint infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, gonorrhea, inhalational anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections, and urinary tract infections.

  • Climara (estradiol)

    (Estradiol)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from hypogonadism or primary ovarian failure, and for the prevention of postmenopausal osteoporosis, with specific limitations on its use for atrophy and osteoporosis.

  • Climara pro

    (Estradiol and Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.

  • Eovist (gadoxetate disodium)

    (Gadoxetate Disodium)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: EOVIST is indicated for intravenous use in MRI of the liver, helping to detect and characterize lesions in patients with known or suspected focal liver disease.

  • Feridex i.v. (ferumoxides)

    (ferumoxides)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Feridex I.V. is indicated for intravenous use as an adjunct to MRI in adults, enhancing T2 weighted images for detecting and evaluating liver lesions associated with changes in the reticuloendothelial system (RES).

  • Gadavist (gadobutrol)

    (gadobutrol)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Gadavist is indicated for MRI of the CNS, breast, magnetic resonance angiography (MRA), and cardiac MRI to detect abnormalities, assess malignant breast disease, evaluate artery disease, and assess myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease.

  • Gadavist (gadobutrol)

    (gadobutrol)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Gadavist is indicated for use in MRI to detect CNS abnormalities, assess malignant breast disease in adults, evaluate supra-aortic or renal artery disease through MRA, and perform cardiac MRI to evaluate myocardial perfusion and late gadolinium enhancement in adults with suspected coronary artery disease.